Literature DB >> 31341718

Treating chronic migraine in CADASIL with calcitonin gene-related peptide receptor antagonism.

Eric D Goldstein1, Mohammed K Badi1, James F Meschia1.   

Abstract

Entities:  

Year:  2019        PMID： 31341718      PMCID： PMC6615658          DOI： 10.1212/CPJ.0000000000000651

Source DB:  PubMed          Journal:  Neurol Clin Pract        ISSN： 2163-0402


× No keyword cloud information.
  7 in total

Review 1.  Development and testing of the Migraine Disability Assessment (MIDAS) Questionnaire to assess headache-related disability.

Authors:  W F Stewart; R B Lipton; A J Dowson; J Sawyer
Journal:  Neurology       Date:  2001       Impact factor: 9.910

2.  Verifying the stroke-free phenotype by structured telephone interview.

Authors:  J F Meschia; T G Brott; F E Chukwudelunzu; J Hardy; R D Brown; I Meissner; L J Hall; E J Atkinson; P C O'Brien
Journal:  Stroke       Date:  2000-05       Impact factor: 7.914

3.  Safety and efficacy of erenumab for preventive treatment of chronic migraine: a randomised, double-blind, placebo-controlled phase 2 trial.

Authors:  Stewart Tepper; Messoud Ashina; Uwe Reuter; Jan L Brandes; David Doležil; Stephen Silberstein; Paul Winner; Dean Leonardi; Daniel Mikol; Robert Lenz
Journal:  Lancet Neurol       Date:  2017-04-28       Impact factor: 44.182

4.  A six-item short-form survey for measuring headache impact: the HIT-6.

Authors:  M Kosinski; M S Bayliss; J B Bjorner; J E Ware; W H Garber; A Batenhorst; R Cady; C G H Dahlöf; A Dowson; S Tepper
Journal:  Qual Life Res       Date:  2003-12       Impact factor: 4.147

5.  The trigeminovascular system and migraine: studies characterizing cerebrovascular and neuropeptide changes seen in humans and cats.

Authors:  P J Goadsby; L Edvinsson
Journal:  Ann Neurol       Date:  1993-01       Impact factor: 10.422

6.  CADASIL: Migraine, Encephalopathy, Stroke and Their Inter-Relationships.

Authors:  Rhea Yan Ying Tan; Hugh Stephen Markus
Journal:  PLoS One       Date:  2016-06-16       Impact factor: 3.240

Review 7.  CADASIL and CARASIL.

Authors:  Saara Tikka; Marc Baumann; Maija Siitonen; Petra Pasanen; Minna Pöyhönen; Liisa Myllykangas; Matti Viitanen; Toshio Fukutake; Emmanuel Cognat; Anne Joutel; Hannu Kalimo
Journal:  Brain Pathol       Date:  2014-09       Impact factor: 6.508
  7 in total
  2 in total

Review 1.  Real-World Patient Experience of CGRP-Targeting Therapy for Migraine: a Narrative Review.

Authors:  Ann M Murray; Jennifer I Stern; Carrie E Robertson; Chia-Chun Chiang
Journal:  Curr Pain Headache Rep       Date:  2022-09-05

2.  The potential danger of blocking CGRP for treating migraine in CADASIL patients.

Authors:  Irene de Boer; Antoinette MaassenVanDenBrink; Gisela M Terwindt
Journal:  Cephalalgia       Date:  2020-07-13       Impact factor: 6.292
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.